Gamma 2-MSH immunoreactivity in the human heart

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Molecular Biology

Background:

• gamma-2 melanocyte-stimulating hormone (MSH) is a peptide derived from proopiomelanocortin (POMC).
• This peptide is known to exert significant hemodynamic effects.
• An arterial-venous difference in MSH was observed in patients during aorto-coronary bypass surgery.

Purpose of the Study:

• To investigate the presence and concentration of gamma-2 MSH within human heart tissue.
• To determine if the human heart is a potential site for gamma-2 MSH production or storage.

Main Methods:

• Human heart tissue samples (right atrium and right ventricle) were obtained.
• A two-step extraction procedure was employed for peptide isolation.
• Sensitive and specific radioimmunoassays were used to quantify gamma-2 MSH levels.
• High-performance liquid chromatography (HPLC) confirmed the identity of the immunoreactive peptide.

Main Results:

• Immunoreactive gamma-2 MSH was detected in both the right atrium and right ventricle.
• Mean concentrations were 0.14 +/- 0.023 pmol/g in the right atrium and 0.12 +/- 0.017 pmol/g in the right ventricle.
• HPLC analysis showed that 80-90% of the immunoreactivity matched synthetic gamma-2 MSH, confirming its identity.

Conclusions:

• The human heart, specifically the atria and ventricles, contains gamma-2 MSH.
• These findings suggest a potential local role for gamma-2 MSH within the cardiovascular system.
• Further research is warranted to elucidate the precise function of cardiac gamma-2 MSH.